COVID-19
Eurofins Launches Reagents for Automated Extraction of Genomic SARS-CoV-2 RNA from Clinical Swab Samples
Eurofins Technologies (Luxembourg) has launched reagents for automated isolation of high-quality SARS-CoV-2 RNA (ribonucleic acid) from viral particles of human respiratory specimens.
Latest COVID-19 News
- Vela Diagnostics' ViroKey SARS-CoV-2 RT-PCR Test Granted FDA Emergency Use Authorization
- UK Government to Roll Out Millions of 90 Minute COVID-19 Test Kits from DnaNudge and Oxford Nanopore
- No-Touch, Paper-Based COVID-19 Diagnostic Test Could Detect SARS-CoV-2 Using Electrical Frequencies
- NIH Clinical Trial to Evaluate Antibodies and Experimental Therapeutics for COVID-19
- Eurofins Clinical Diagnostics Launches Lower Cost Highly Accurate COVID-19 PCR Test
- Johnson & Johnson to Supply US Government with 100 Million Doses of Investigational COVID-19 Vaccine
- Thermo Fisher Launches New High-Throughput, Fully Automated, Real-Time PCR Solution for COVID-19 Testing
- Novavax COVID-19 Vaccine Elicits Wild-Type Virus Neutralizing Antibody Responses in 100% of Participants in Phase 1/2 Trial
- BioNTech Begins Phase 1 Trial of mRNA-based COVID-19 Vaccine Candidate with Fosun Pharma in China
- Bio-Techne and Mount Sinai Launch Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO Kit
- FDA Could Issue Emergency Use Authorization for COVID-19 Vaccine Within Weeks After Clinical Trial Data Meet Efficacy Requirements
- Quidel Receives NIH Funding to Accelerate Capacity Expansion for Manufacturing Sofia SARS-CoV-2 Antigen Detection Test
- Snibe Diagnostic’s Maglumi SARS-CoV-2 S-RBD IgG Test Receives CE Mark
- First Molecular T Cell Monitoring Tool for SARS-CoV-2 Launched
- Potential Medical Solution Utilizes Nanobody Technology for Detection and Treatment of COVID-19
- Regeneron’s COVID-19 Antibody Drug Cocktail Completely Blocks Coronavirus Infection in Animal Test
- Mammoth Biosciences’ CRISPR SARS-CoV-2 Diagnostic Platform Becomes First CRISPR-Based Initiative to Be Funded by NIH
- Slight Variability in Coronavirus Mutations Could Make COVID-19 Vaccine Effective Against All SARS-CoV-2 Strains
- Imperial College Begins Immunizing Hundreds of People with Experimental COVID-19 Vaccine in Early Trial
- COVID-19 Vaccine Could Give Immunity for At Least 12 Months, Says AstraZeneca
- Rapid COVID-19 Test Uses Graphene-Enhanced Sensor to Produce Signal After Positively Identifying Viral Antigens
- Researchers Testing Do-It-Yourself COVID-19 Vaccine on Themselves
- Eli Lilly Begins Phase 3 Trial of Human Antibody LY-CoV555 for Prevention of COVID-19
- First FDA EUA COVID-19 Saliva Testing Kits Launched
- Pfizer and BioNTech to Supply Japan with 120 Million Doses of mRNA-Based COVID-19 Vaccine
- Applied DNA’s COVID-19 Diagnostic Kit Granted FDA EUA Amendment for Use on Widely Installed RT-PCR Device and High-Throughput RNA Extraction Robotics
- Merck’s First COVID-19 Vaccine Candidate to Enter Phase 1 Clinical Trial in Q3
- Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2
- Diazyme Partners with Maccura Biotechnology to Launch FDA EUA Approved SARS-CoV-2 RT-PCR Diagnostics Test